TITLE

An Epidemiological Study of Vulvovaginal Candidiasis in Women of Childbearing Age

AUTHOR(S)
Jindal, N.; Gill, P.; Aggarwal, A.
PUB. DATE
April 2007
SOURCE
Indian Journal of Medical Microbiology;Apr2007, Vol. 25 Issue 2, p175
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
26050598

 

Related Articles

  • Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. Rathod, Sujit D.; Buffler, Patricia A. // BMC Women's Health;2014, Vol. 14 Issue 1, p1 

    Background: Available literature concerning the epidemiologic or clinical features of vulvovaginal candidiasis commonly reports that: 75% of women will experience an episode of vulvovaginal candidiasis in their lifetimes, 50% of whom will experience at least a second episode, and 5-10% of all...

  • Treatment of Recurrent Vulvovaginal Candidiasis. DAVIS, J. DELRENE; HARPER, AMY L. // American Family Physician;6/15/2011, Vol. 83 Issue 12, p1482 

    The article discusses a treatment regimen for recurrent vulvovaginal candidiasis. According to the article, a six-month treatment consisting of antifungal agent reduces the risk of return of vulvovaginal candidiases. Results of several studies of reproductive-aged women with recurrent...

  • Vulvovaginal Candidiasis--What We Do and Do Not Know. Sobei, Jack D. // Annals of Internal Medicine;Sep84, Vol. 101 Issue 3, p390 

    Discusses vulvovaginal candidiasis. Factor that hampers progress in understanding the pathogenesis and epidemiology of recurrent vulvovaginal candidiasis; Predisposing factors that are widely thought to increase the risk of vulvovaginal candidiasis; Issue on managing recurrent or chronic...

  • Identification of Candida Species among Patients with Vulvovaginal Candidiasis in Kashan by PCR-RFLP Method. Mohammadi, Rasoul; Nazeri, Mehdi; Mesdaghinia, Elaheh; Mirhendi, Seyed Hossein // Journal of Isfahan Medical School;2/6/2012, Vol. 29 Issue 165, p1 

    Background: Vulvovaginal candidiasis (VVC) is a common vaginal infection, affecting up to 75% of women in child-bearing age. Approximately 5% of patients may experience recurrent VVC. Candida albicans is the most common causative agent with a prevalence of approximately 70-90%. Nonalbicans...

  • Fluconazole for recurrent vulvovaginal candidiasis. Chambers, Christopher V. // Patient Care;Nov2004, Vol. 38 Issue 11, p69 

    Focuses on a study on the use of the drug fluconazole for treating recurrent vulvovaginal candidiasis. Percentage of the patients treated with fluconazole who became disease-free; Factors that physicians should consider before treating women with recurrent vulvovaginal candidiasis; Implications...

  • FREQUENCY OF VULVOVAGINAL CANDIDIASIS IN 19-65 YEARS OLD WOMEN IN LAR IN 2011. Jourkesh, Fatemeh; Salehi, Zahra; Moumeni, Babak // Jundishapur Journal of Microbiology;2013 Special Edition, p78 

    Introduction and Objectives: Vulvovaginal candidiasis is the second common fungal infection among women. Almost 75% of the women in their life have faced it. In the past three decades, the rate of attacking fungal infections has been increasing. The majority of cases of vulvovaginal candidiasis...

  • Prevalence of vulvovaginal candidiasis and frequency of Candida speices in women referred to gynecology obstetrics clinic at Kashan-Iran since 2008 to 2010. Nazeri, Mahdi; Mesdaghinia, Elahe; Moraveji, Seyed Ali Reza; Atabakhshiyan, Roya; Soleymani, Fateme // Journal of Mazandaran University of Medical Sciences (JMUMS);Feb2012, Vol. 22 Issue 86, p261 

    Background and purpose: Vulvovaginal candidiasis (VVC) often referred to as a yeast infection which is a common gynecologic problem, affecting %75 of women during their lifetimes. More than 40% of affected women will have 2 or more VVC episodes. Candida albicans is the most agent of VVC; however...

  • CANDIDA SPECIES IN VULVOVAGINAL CANDIDIASIS PATIENTS FROM THE TOWN TAIBAD IN IRAN; IDENTIFIED BY PCR-RFLP METHOD. Zabardast, Habibeh; Moazeni, Maryam; Daie-Ghazvini, Roshanak; Noori Jalyani, Keramat Allah; Rezaie, Sassan // Jundishapur Journal of Microbiology;2013 Special Edition, p66 

    Introduction and Objectives: Vulvovaginal candidiasis (VVC) is caused by overgrowth of members of the genus Candida in the vagina and is described by curd-like vaginal discharge, itching, and erythema. It affects 75% of all women at least once in their lifetime, especially during childbearing...

  • Vaginal Impact of the Oral Administration of Total Freeze-Dried Culture of LCR 35 in Healthy Women. Bohbot, J. M.; Cardot, J. M. // Infectious Diseases in Obstetrics & Gynecology;2012, p1 

    The use of probiotics in the prevention or treatment of some vaginal infections has been the subject of numerous studies. To assess the presence of Lactobacillus casei rhamnosus (LCR35) in the vagina after an oral administration, an open randomised pilot study was conducted on 20 healthy women...

  • Epidemiologic Features of Vulvovaginal Candidiasis among Reproductive-Age Women in India. Rathod, Sujit D.; Klausner, Jeffrey D.; Krupp, Karl; Reingold, Arthur L.; Madhivanan, Purnima // Infectious Diseases in Obstetrics & Gynecology;2012, p1 

    Background. Vulvovaginal candidiasis is characterized by curd-like vaginal discharge and itching, and is associated with considerable health and economic costs. Materials and Methods. We examined the incidence, prevalence, and risk factors for vulvovaginal candidiasis among a cohort of 898 women...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics